Recital 11, Decision_act (EU) 2023/1097

In forcesince 5 Jun 2023

The opinions of 10 December 2019 did not contain any information as to whether a safe threshold can be derived in relation to endocrine-disrupting properties of cyanamide, and, if so, whether the risks of using the representative biocidal products presented in the application for approval of cyanamide for product-types 3 and 18 could be considered acceptable or not, in relation to the endocrine-disrupting properties of cyanamide.